Compounding Pharmacy · Livonia, MI · 503A
Vios Compounding Review
Vios Compounding (legal entity SNF Holdings, LLC dba Vios Compounding) is a 503A compounding pharmacy in Livonia, Michigan that compounds semaglutide and tirzepatide (GLP-1), including injectable vials (1 mg or 5 mg strength in 1 mL or 2.5 mL) and GLP-1 oral strips/transmucosal films, prepared per individual prescription. The FDA issued a state referral letter to the pharmacy in April 2024. Note: routine 503A compounding of GLP-1s that copy commercially available products is restricted now that the FDA shortages are resolved.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Top-Rated GLP-1 Partners
Not sourced from Vios Compounding — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
No insurance needed · HSA/FSA eligible · vetted by our editors
Sunlight
Compounded GLP-1 with unlimited telehealth visits and free shipping
Starting price: $159/mo
Get started →Read review Sunlight →MadeMed
Compounded GLP-1 in both injection and oral forms
Starting price: $219/mo
Get started →Read review MadeMed →Breeze Meds
Compounded GLP-1 access with named prescribers and 4-pharmacy network
Starting price: $169/mo
Get started →Read review Breeze Meds →| Provider | Starting price | |
|---|---|---|
7.3Sunlight | $159/mo | Get started → |
7.4MadeMed | $219/mo | Get started → |
8.3Found | $99/mo | Get started → |
7.4Breeze Meds | $169/mo | Get started → |
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
We have not verified any third-party accreditations for this pharmacy beyond its state pharmacy license.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed
Vios Compounding has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.
Regulatory Actions
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
Medium confidence · Last verified 2026-06-04 via manual · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology — as of July 2026
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.